T. Rowe Price Associates
DH icon

T. Rowe Price Associates’s Definitive Healthcare DH Stock Holding History

T. Rowe Price Associates’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,961
Closed -$24K – 3265
2026
Q1 		$24K Hold
18,961
– – ﹤0.01% 3113
2025
Q4 		$55K Hold
18,961
– – ﹤0.01% 3022
2025
Q3 		$77K Sell
18,961
-5,960
-24% -$23.8K ﹤0.01% 2967
2025
Q2 		$98K Buy
24,921
+3,556
+17% +$11.2K ﹤0.01% 2895
2025
Q1 		$62K Buy
21,365
+793
+4% +$3.22K ﹤0.01% 2901
2024
Q4 		$85K Buy
20,572
+3,496
+20% +$15.3K ﹤0.01% 2865
2024
Q3 		$77K Hold
17,076
– – ﹤0.01% 2868
2024
Q2 		$94K Buy
17,076
+3,685
+28% +$23.2K ﹤0.01% 2768
2024
Q1 		$109K Buy
13,391
+1,387
+12% +$12.3K ﹤0.01% 2765
2023
Q4 		$120K Buy
12,004
+1,332
+12% +$10.5K ﹤0.01% 2687
2023
Q3 		$86K Buy
+10,672
New +$107K ﹤0.01% 2693
2022
Q3 		– Sell
-1,074,658
Closed -$24.6M – 2974
2022
Q2 		$24.6M Buy
1,074,658
+540,840
+101% +$11.6M ﹤0.01% 1119
2022
Q1 		$13.2M Sell
533,818
-762,087
-59% -$17.2M ﹤0.01% 1327
2021
Q4 		$35.4M Buy
1,295,905
+45,905
+4% +$1.61M ﹤0.01% 1120
2021
Q3 		$53.5M Buy
+1,250,000
New +$55.5M 0.01% 981

Other funds holding DH

AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

T. Rowe Price Associates's DH Position: Q2 2026 in Review

T. Rowe Price Associates sold out of Definitive Healthcare (DH) in Q2 2026, closing a stake of 18,961 shares — an estimated $24K sold.

T. Rowe Price Associates first reported a position in DH in Q3 2021 and held it in 15 quarters. The position peaked at $53.5M in Q3 2021. 100 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • T. Rowe Price Associates reported no remaining Definitive Healthcare position as of Q2 2026 after selling out during the quarter.
  • T. Rowe Price Associates sold 18,961 Definitive Healthcare shares in Q2 2026, an estimated $24K.
  • T. Rowe Price Associates first reported a position in Definitive Healthcare in Q3 2021 and held it in 15 quarters.
  • T. Rowe Price Associates's Definitive Healthcare position peaked at $53.5M in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.